Your Partner for Growth, Hybridan

Hybridan

Your Partner for Growth

Our passion is raising growth capital for exciting, fast growth companies that want to take their business to the next level. We raise capital for companies both listed and unlisted in the most efficient manner possible and pride ourselves as being one of the few consistently profitable broking firms in the City. This has been achieved through a highly disciplined approach when seeking to create both corporate and institutional relationships.

Equity Bottom-Up

4 Global PLC operates as a technology and professional services company. The Company offers an extensive sport and activity software and data platforms for sports and health business. 4 Global serves customers in the United Kingdom.

<ul>
<li>The provider of data and technology for sports, fitness and wellness organisations to optimise operational and investment decisions, announced that, following a competitive tender, it has secured a contract renewal and expansion with Sport England worth up to £4m over four years in equal terms.</li>
<li>Sport England initially procured 4GLOBAL in 2021 to provide performance data from public leisure facilities through its platform, Moving Communities, a decision-support tool that uses 4GLOBAL's dataset to aid understanding of where and how people engage in physical activity, enabling a more evidence-based approach to public investment.</li>
<li>The platform has since played a central role in programmes such as the National Leisure Recovery Fund and the Swimming Pool Support Fund, tracking over 9 million active people across 1,000+ leisure facilities daily.</li>
</ul>


The provider of data and technology for sports, fitness and wellness organisations to optimise operational and investment decisions, announced that, following a competitive tender, it has secured a contract renewal and expansion with Sport England worth up to £4m over four years in equal terms.
Sport England initially procured 4GLOBAL in 2021 to provide performance data from public leisure facilities through its platform, Moving Communities, a decision-support tool that uses 4GLOBAL's dataset to aid understanding of where and how people engage in physical activity, enabling a more evidence-based approach to public investment.
The platform has since played a central role in programmes such as the National Leisure Recovery Fund and the Swimming Pool Support Fund, tracking over 9 million active people across 1,000+ leisure facilities daily.


Surface Transforms plc develops carbon fibre reinforced ceramic braking and friction materials used in a variety of specialized markets, including Formula 1 racing, aircraft, aerospace, rail, road cars and transport vehicles.  The Group has alliances with Formula 1 Motor Racing teams, as well as manufacturers of aircraft and rail braking systems.

<ul>
<li>The specialist in currency risk management and alternative banking, reports finals to December 2024.</li>
<li>Its revenue is £50.3m up from £49.9m, with growth in the number of clients offset by a reduction in average spend.</li>
<li>The EBITDA margin of 8% is ahead of previous expectations and operating loss of £0.2m compared to an operating profit of £8.1m. </li>
</ul>


The specialist in currency risk management and alternative banking, reports finals to December 2024.
Its revenue is £50.3m up from £49.9m, with growth in the number of clients offset by a reduction in average spend.
The EBITDA margin of 8% is ahead of previous expectations and operating loss of £0.2m compared to an operating profit of £8.1m. 


Surface Transforms PLC - Duplicate of Hybridan Small Cap Feast: 02/04/2025

Active Energy Group PLC, through subsidiaries, provides biomass fuel and energy efficient solutions to reduce energy consumption and CO2 emissions.

<ul>
<li>The international biomass based renewable energy business, today announced that its European patent application has been allowed under a Patent Application for its innovative "Process for Beneficiating and Cleaning Biomass".</li>
<li>This forthcoming Patent strengthens the intellectual property portfolio underpinning the Company's CoalSwitch technology, a next-generation solution for producing sustainable biomass fuel.</li>
<li>The newly allowed patent application will grant protection in several EU countries reinforcing Active Energy's innovation in the global biomass industry.</li>
</ul>


The international biomass based renewable energy business, today announced that its European patent application has been allowed under a Patent Application for its innovative "Process for Beneficiating and Cleaning Biomass".
This forthcoming Patent strengthens the intellectual property portfolio underpinning the Company's CoalSwitch technology, a next-generation solution for producing sustainable biomass fuel.
The newly allowed patent application will grant protection in several EU countries reinforcing Active Energy's innovation in the global biomass industry.


Zentra Group PLC operates as a property development and management company. The Company focuses on residential sectors and provides investment management services. Zentra Group serves customers in the United Kingdom.

<ul>
<li>Zentra Group PLC (ZNT) announced their Interim Results for the six months ending 31 December 2024.</li>
<li>We have published research on this which is attached and a snapshot of the research is below.</li>
<li>The interims to December 2024 report six months of significant restructuring.</li>
</ul>


Zentra Group PLC (ZNT) announced their Interim Results for the six months ending 31 December 2024.
We have published research on this which is attached and a snapshot of the research is below.
The interims to December 2024 report six months of significant restructuring.


Hybridan Research: Zentra Group Plc: Solid Cornerstones

Crism Therapeutics Corporation is a pharmaceutical manufacturing company. The Company specializes in improving the clinical implementation of active pharmaceutical ingredients (APIs) through local drug delivery and personalized medicines. Crism Therapeutics serves clients worldwide.

<ul>
<li>The UK drug delivery company focused on the localised delivery of chemotherapy drugs, announced that it has been awarded a grant by Innovate UK to support the pre-clinical development of the Company's proprietary ChemoSeed technology in prostate cancer.</li>
<li>The Project is in line with the Company's strategy as detailed in the admission document published when CRISM joined the AIM market last year and which highlighted the potential of ChemoSeed in multiple disease areas.</li>
<li>The Innovate UK grant was awarded as part of the Government's 'Launchpad: life and health sciences, Northern Ireland - Rd2 MFA'. </li>
</ul>


The UK drug delivery company focused on the localised delivery of chemotherapy drugs, announced that it has been awarded a grant by Innovate UK to support the pre-clinical development of the Company's proprietary ChemoSeed technology in prostate cancer.
The Project is in line with the Company's strategy as detailed in the admission document published when CRISM joined the AIM market last year and which highlighted the potential of ChemoSeed in multiple disease areas.
The Innovate UK grant was awarded as part of the Government's 'Launchpad: life and health sciences, Northern Ireland - Rd2 MFA'. 


Hybridan Small Cap Feast is "Our daily digest of news from UK Small Caps". 

Hybridan Friday Takeaway is "This will delve a little deeper on individual companies and focus on non-house stocks under £200m market capitalisation to help raise awareness". 

Corporate Research is our equity research on smaller companies